These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18833969)

  • 1. Cardiac resynchronization therapy in chronic heart failure.
    Petkar S; Luckie M; Khattar RS
    Br J Hosp Med (Lond); 2008 Jul; 69(7):392-8. PubMed ID: 18833969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy for heart failure.
    Abraham WT; Hayes DL
    Circulation; 2003 Nov; 108(21):2596-603. PubMed ID: 14638522
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac resynchronization therapy: a review of clinical trials and criteria for identifying the appropriate patient.
    Abraham WT
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S30-7. PubMed ID: 12776011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathobiology of left ventricular dyssynchrony and resynchronization.
    Spragg DD; Kass DA
    Prog Cardiovasc Dis; 2006; 49(1):26-41. PubMed ID: 16867848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization pacing therapy.
    Casey C; Knight BP
    Cardiology; 2004; 101(1-3):72-8. PubMed ID: 14988628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of dual site left ventricular cardiac resynchronization therapy in a patient with congestive heart failure.
    Sassara M; Achilli A; Bianchi S; Ficili S; Marullo A; Pontillo D; Achilli P; Peraldo C; Sgreccia F
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):805-7. PubMed ID: 15189538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure patients selection for cardiac resynchronization therapy.
    Geng J; Wu B; Zheng L; Zhu J
    Eur J Intern Med; 2011 Feb; 22(1):32-8. PubMed ID: 21238890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics of patients recruited into the CARE-HF study.
    Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Klein W; Tavazzi L;
    Eur J Heart Fail; 2005 Mar; 7(2):205-14. PubMed ID: 15701468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of left ventricular mass and wall thickness after cardiac resynchronization therapy: proof of pathophysiological concept.
    Mannaerts H
    Eur Heart J; 2006 Jun; 27(12):1392-3. PubMed ID: 16720689
    [No Abstract]   [Full Text] [Related]  

  • 12. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment.
    Bleeker GB; Bax JJ; Steendijk P; Schalij MJ; van der Wall EE
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):213-9. PubMed ID: 16568130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?
    Cleland JG; Nasir M; Tageldien A
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):90-101. PubMed ID: 17245403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to assess the nonresponder to cardiac resynchronization therapy-a comprehensive stepwise approach.
    Kutyifa V; Breithardt OA
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):504-10. PubMed ID: 22521484
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac resynchronization therapy: overcoming ventricular dyssynchrony in dilated heart failure.
    Kerwin WF; Paz O
    Cardiol Rev; 2003; 11(4):221-39. PubMed ID: 12852801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure.
    Valzania C; Gadler F; Eriksson MJ; Olsson A; Boriani G; Braunschweig F
    Eur J Heart Fail; 2007; 9(6-7):644-50. PubMed ID: 17347041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac resynchronization for asymptomatic or mildly symptomatic heart failure: a bridge too far?
    Leclercq C; Mabo P; Trochu JN
    J Am Coll Cardiol; 2008 Dec; 52(23):1844-1846. PubMed ID: 19038681
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac resynchronization therapy for heart failure shows great promise.
    Ovsyshcher IE; Auricchio A
    Isr Med Assoc J; 2003 Aug; 5(8):589-91. PubMed ID: 12929300
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure-volume loop analysis.
    Penicka M; Kocka V; Herman D; Trakalova H; Herold M
    Eur J Heart Fail; 2010 Jun; 12(6):634-6. PubMed ID: 20436036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.